Страна: Австралія
мова: англійська
Джерело: Department of Health (Therapeutic Goods Administration)
ramipril, Quantity: 1.25 mg
Alphapharm Pty Ltd
Ramipril
Capsule, hard
Excipient Ingredients: pregelatinised maize starch; titanium dioxide; purified water; iron oxide yellow; sorbitan monolaurate; Gelatin; sodium lauryl sulfate; propylene glycol; brilliant blue FCF; indigo carmine; butan-1-ol; quinoline yellow; allura red AC; iron oxide black; SD alcohol 45; SD alcohol 3-A
Oral
10, 21, 7 (starter), 30
(S4) Prescription Only Medicine
Treatment of hypertension. Data are currently not available to support the use of Tryzan Caps in renovascular hypertension. Post myocardial infarction heart failure. Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1 g/day. For reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularisation procedures in patients 55 years of age or more who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease. For reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularisation procedures in diabetic patients 55 years or more with one or more of the following risk factors: systolic blood pressure >160 mmHg or diastolic blood pressure >90 mmHg (or on antihypertensive treatment); total cholesterol >5.2 mmol/L; HDL cholesterol <0.9 mmol/L; current smoker; known microalbuminuria; any evidence of previous vascular disease
Visual Identification: Hard gelatin capsule with white opaque body and yellow opaque cap. The body has 'G' and cap has 'RM 1.25' both printed in black. Capsules contain a white to off-white powder.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2007-06-28
TRYZAN ® CAPS; TRYZAN ® TABS _ramipril_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about TRYZAN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking TRYZAN against the benefits expected for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT TRYZAN IS USED FOR TRYZAN contains the active ingredient ramipril. It belongs to a group of medicines called angiotensin converting enzyme (ACE) inhibitors. TRYZAN is used to treat: • high blood pressure (hypertension) • some heart conditions such as heart failure after a heart attack • kidney problems in some patients TRYZAN is also used to reduce the risk of cardiovascular problems and complications in patients aged 55 years or more with heart or blood vessel disease, or diabetes. HYPERTENSION TRYZAN is used to lower high blood pressure (hypertension). Everyone has blood pressure. This pressure helps get your blood all around your body. Your blood pressure may be different at different times of the day and can be influenced by how busy or worried you are. You have hypertension when your blood pressure stays higher than is needed, even when you are calm and relaxed. There are usually no symptoms of hypertension. The only way of knowing that you have hypertension is to have your blood pressure checked on a regular basis. If high blood pressure is not treated it can lead to serious health problems, including stroke, heart disease and kidney failure. HEART FAILURE AFTER A HEART ATTACK TRYZAN may be used after a heart attack. A heart attack occurs when one of the major blood vessels supplying blood to your heart becomes blocked. This means that your heart muscle cannot receive the oxygen it needs and becomes damaged. This may lead to further problems, su Прочитайте повний документ
AUSTRALIAN PRODUCT INFORMATION TRYZAN ® CAPS TRYZAN ® TABS _ramipril _ 1 NAME OF THE MEDICINE ramipril 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each TRYZAN CAPS capsule contains ramipril 1.25 mg, 2.5 mg, 5 mg or 10 mg as the active ingredient. Each TRYZAN TABS tablet contains ramipril 1.25 mg, 2.5 mg, 5 mg or 10 mg as the active ingredient. Excipient with known effect: TRYZAN CAPS contain phenylalanine and sulfites. TRYZAN TABS contain sugars as lactose. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM TRYZAN CAPS TRYZAN CAPS 1.25: Each TRYZAN CAPS 1.25 capsule has a white opaque body and a yellow opaque cap. The body has ‘G’ and the cap has ‘RM 1.25’ printed in black ink. Capsules contain a white to off-white powder. TRYZAN CAPS 2.5: Each TRYZAN CAPS 2.5 capsule has a white opaque body and an orange opaque cap. The body has ‘G’ and the cap has ‘RM 2.5’ printed in black ink. Capsules contain a white to off-white powder. TRYZAN CAPS 5: Each TRYZAN CAPS 5 capsule has a white opaque body and a swedish orange opaque cap. The body has ‘G’ and the cap has ‘RM 5’ printed in black ink. Capsules contain a white to off-white powder. TRYZAN CAPS 10: Each TRYZAN CAPS 10 capsule has a white opaque body and a blue opaque cap. The body has ‘G’ and the cap has ‘RM 10’ printed in black ink. Capsules contain a white to off-white powder. TRYZAN TABS TRYZAN TABS 1.25: white to off-white, capsule-shaped, uncoated, flat tablets. TRYZAN TABS 2.5: yellow, capsule-shaped, uncoated, flat tablets, scored on one side and side walls, marked R2. TRYZAN TABS 5: pink, capsule-shaped, uncoated, flat tablets, scored on one side and side walls, marked R3. TRYZAN TABS 10: white to off-white, capsule-shaped, uncoated, flat tablets, scored on one side and side walls, marked R4. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • Treatment of hypertension. Data are currently not available to support the use of ramipril in renovascular hypertension • Post myocardial infa Прочитайте повний документ